No Data
No Data
Dow Dips Over 250 Points; Genesco Shares Plunge After Q4 Results
Plus Therapeutics PSTV Phase 1 Data; Acurx Pharmaceuticals ACXP Offering
Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30%
Nasdaq Gains 100 Points; US Economy Adds Fewer Jobs Than Projected
Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
Acurx Announces Publication Of Nonclinical In Vivo Data In The Journal Of Antimicrobial Agents And Chemotherapeutics Entitled: "Microbiome Impact Of Ibezapolstat And Other Clostridioides Difficile Infection-relevant Antibiotics Using Humanized Mice"...